logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Urological Cancers 1st Edition Sarah Ngan Bmedsci Mbbs Mrcp Jonathan Waxman Bsc

  • SKU: BELL-4413078
Urological Cancers 1st Edition Sarah Ngan Bmedsci Mbbs Mrcp Jonathan Waxman Bsc
$ 31.00 $ 45.00 (-31%)

5.0

50 reviews

Urological Cancers 1st Edition Sarah Ngan Bmedsci Mbbs Mrcp Jonathan Waxman Bsc instant download after payment.

Publisher: Springer-Verlag London
File Extension: PDF
File size: 4.62 MB
Pages: 342
Author: Sarah Ngan BMedSci, MBBS, MRCP, Jonathan Waxman BSc, MD, FRCP (auth.), Jonathan Waxman BSc, MD, FRCP (eds.)
ISBN: 9781846280153, 9781852339111, 184628015X, 185233911X
Language: English
Year: 2005
Edition: 1

Product desciption

Urological Cancers 1st Edition Sarah Ngan Bmedsci Mbbs Mrcp Jonathan Waxman Bsc by Sarah Ngan Bmedsci, Mbbs, Mrcp, Jonathan Waxman Bsc, Md, Frcp (auth.), Jonathan Waxman Bsc, Md, Frcp (eds.) 9781846280153, 9781852339111, 184628015X, 185233911X instant download after payment.

Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations.

This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.

Related Products